Pall Corporation

The Future is Modular…

The Future is Allegro Connect Systems

Join us for the Virtual Launch Event


Take a closer look at the Allegro Connect Systems

The complete solution for fast, cost-effective,
and flexible drug manufacture.


Date: Wednesday, September 28, 2022 (multiple sessions)
Duration: 60 Minutes

We are excited to invite you to join us for the launch event where we will unveil our new range of modular Allegro Connect Systems. 

The systems can be constructed into a more complex arrangement to facilitate solutions that deliver the same process agility for all manufacturing processes. They will help you achieve new levels of control, performance, scalability, and productivity while adhering to all cGMP standards.

During the event, our team will take you from the origins of the concept to the launch of the systems and explain how the complete solution offers new opportunities to support your manufacturing demands.

Hosted By

  • Giridaran Ganesan

    Global Product Manager - Modular Bioprocess Systems

    Giridaran (Daran) is a Global Product Manager for Modular Bioprocess Systems. Prior to joining us, Daran worked in Operations and as an MSAT Process Expert. He has extensive experience in 20 kL manufacturing, tech transfer for 2 kL single-use scale, process design and process validation. Daran holds a degree in Biotechnology from Anna University, India. He enjoys baking and an early morning run, and he is a huge fan of craft beers.

  • Gareth Leach

    Global Marketing Leader

    Gareth has 28 years of experience working in the Bioprocessing Field. He is a Ph.D. scientist by training and joined Pall initially as an application specialist, spending time in system engineering, before moving into marketing. Gareth currently has a global leadership position in the marketing team of Pall Biotech.

  • Mark Ayles

    Senior Marketing Manager

    Mark has twenty years of experience working with many of the world’s most respected drug manufacturers, testing our technology to resolve manufacturing challenges and training operators to ensure trouble-free operation and compliance. Now in Marketing, he calls upon this knowledge and experience to provide context to our developing portfolio and to ensure all content and communications are clear and resonate with users’ real-world challenges. He is a keen dog walker and yachtsman and regularly explores the south coast of the UK by land and by sea.

  • Dr. Rahul Fadnis

    Senior Principal Investigator and Head of Viral Testing Facility, Syngene International Limited

    Dr. Rahul S. Fadnis, PhD, is a biotech professional with over 15 years of industry experience in the areas of Viral Safety, Clearance and Vaccine Development. He heads the Viral Testing Facility at Syngene International Limited that offers the Viral Clearance and Safety studies to Indian and Global Biopharma Industry.

  • Dr. Aernout Martens

    Global Product Manager Virus Filtration, Pall Biotech

    Aernout Martens started working at Pall as BioPurification Specialist, after which he specialized in Virus Filtration and became Global Product Manager for the Pall Virus Filtration portfolio.

  • Sudhakar Nagaraj

    Principal Scientist, SLS–Global Regulatory and Validation Consulting Group, Pall Biotech

    Sudhakar Nagaraj has been in the Pharmaceutical industry for over 17 years and joined Pall during 2006 in the Scientific Laboratory Services (SLS) organization. He is currently involved in updating Pall’s technical support portfolios with rapidly evolving end-user and regulatory requirements, to streamline customer selection, adoption and successful regulatory approval of Pall technologies.

  • Esha Pillay

    Senior Manager – Scientific & Laboratory Services (SLS), South Asia, Pall Biotech

    In her current role, Esha is responsible for leading the technical teams in the South Asian region to support key Biotech companies. She has over 20 years experience in the Biopharmaceutical field, bringing both scientific and engineering experience in the areas of project management, technical management, training, regulatory support and management of validation and instrumentation calibration laboratories.

  • Dr. Rahul Fadnis

    Senior Principal Investigator and Head of Viral Testing Facility, Syngene International Limited

    Dr. Rahul S. Fadnis, PhD, is a biotech professional with over 15 years of industry experience in the areas of Viral Safety, Clearance and Vaccine Development. He heads the Viral Testing Facility at Syngene International Limited that offers the Viral Clearance and Safety studies to Indian and Global Biopharma Industry.

Allegro Connect Systems - Choose the Perfect Blend for Your Process

Here is a list of topics that will be covered during the event:

  • Modular: The Evolution of System Design

    What is modular and how does it maximize efficiency and improve usability through automation, configurability, and flexibility

  • System Design

    Developed to improve process and user experience
  • Engineered Thoughtfully

    Discover the efficiencies of manufacture from supply chain to simplification of IQ/OQ for our 4 Allegro Connect Systems
  • Discover: Allegro Connect Bulk Fill System

  • Discover: Allegro Connect Depth Filtration System

  • Discover: Allegro Connect Virus Filtration System

  • Discover: Allegro Connect Buffer Management System

  • Questions?

    From Engineers to BioProcess Specialists, ask our SMEs

  • 4:45pm

    Case study 3: End-to-end manufacturing of adenovirus

    TBD

  • 5:15pm

    Party

  • 1:00pm

    Company profile of Pall Biotech

    TBC

  • 1:10pm

    Company profile of Molmed

    TBD

  • 1:20pm

    Industrializing Gene Therapy

    TBD

  • 1:50pm

    Upstream technologies to industrialize gene therapy

    TBD

  • 2:40pm

    Break

  • 2:45pm

    Keynote

    TBD

  • 3:45pm

    Case study 1: Molmed’s implementation of iCELLis technology for lentiviral production

    TBD

  • 4:15pm

    Case study 2: Cost modelling of upstream production for Lentivirus

    TBD

  • 4:45pm

    Case study 3: End-to-end manufacturing of adenovirus

    TBD

  • 5:15pm

    Party

Registration Form

Please complete the form below and click the “Register Now” button.